Showing 4601-4610 of 20465 results for "".
- Ultrasound-Guided Percutaneous Electrolysis Versus Dry Needling In Chronic Low Back Painhttps://reachmd.com/news/ultrasound-guided-percutaneous-electrolysis-versus-dry-needling-in-chronic-low-back-pain/2487404/Key Takeaways Ultrasound-guided percutaneous electrolysis was associated with broader short-term statistical improvement across several reported outcomes than electrical dry needling, although not all between-group differences reached established clinical impor
- MRI Accuracy for Knee Meniscus Tears: Updated Meta-Analysishttps://reachmd.com/news/mri-accuracy-for-knee-meniscus-tears-updated-meta-analysis/2487402/Key Takeaways MRI accuracy was high overall, with sensitivity favoring medial tears and specificity favoring lateral tears. The evidence base included 75 studies, 8,507 patients, 8,517 knees, 28 countries, and used arthroscopy as the reference standard
- Cefepime-Nacubactam and Aztreonam-Nacubactam in Phase 3 cUTI Trialhttps://reachmd.com/news/cefepime-nacubactam-and-aztreonam-nacubactam-in-phase-3-cuti-trial/2487410/Key Takeaways Both nacubactam-based regimens were associated with non-inferior test-of-cure success versus imipenem-cilastatin, and cefepime-nacubactam also met superiority criteria. This global, multicentre, randomized, double-blind phase 3 trial enro
- New Anatomy-Based Framework Targets Prevention of GLP-1 RA-Associated Facial Aginghttps://reachmd.com/news/new-anatomy-based-framework-targets-prevention-of-glp-1-ra-associated-facial-aging/2487408/A conceptual model published online ahead of print in Aesthetic Plastic Surgery proposes an anatomy-driven approach to identifying and preventing facial aging changes associated with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, commonly referred to as “Ozempic face.”
- FDA Adds Bemotrizinol to OTC Sunscreen Monograph in First New UV Filter in Over 20 Yearshttps://reachmd.com/news/fda-adds-bemotrizinol-to-otc-sunscreen-monograph-in-first-new-uv-filter-in-over-20-years/2487644/The US Food and Drug Administration (FDA) has finalized an administrative order adding bemotrizinol as a permitted active ingredient in over-the-counter (OTC) sunscreen products, marking the first addition of a new sunscreen active ingredient to the OTC sunscreen m
- Early Enteral Nutrition After Pancreatoduodenectomy in NUTRIWHIhttps://reachmd.com/news/enteral-nutrition-pancreatoduodenectomy/2487392/Key Takeaways Early supplemental enteral nutrition was associated with a lower 90-day comprehensive complication index after pancreatoduodenectomy in patients with an NRS score of 3 or higher. Overall 90-day morbidity was not statistically different, w
- PACBACK Trial Tests Prevention Strategy for Chronic Low Back Painhttps://reachmd.com/news/pacback-prevention-chronic-back-pain/2487393/Key Takeaways Supported self-management was associated with lower mean low back pain impact than medical care at 10 to 12 months. Spinal manipulation did not differ from medical care, and adding it to supported self-management did not improve outcomes
- Endovascular Treatment of Medium Vessel Occlusionhttps://reachmd.com/news/endovascular-treatment-medium-vessel-occlusion/2487398/Key Takeaways Among patients with medium-vessel occlusion stroke and moderate-to-severe deficits, thrombectomy was associated with a higher rate of functional independence at 90 days than medical management alone. Symptomatic intracranial hemorrhage wa
- Kidney Outcomes with GLP-1 Receptor Agonists in Patients on SGLT2 Therapyhttps://reachmd.com/news/kidney-glp-1-sglt2/2487386/Key Takeaways GLP-1 receptor agonist initiation was linked to less frequent kidney disease progression than DPP-4 inhibitor or sulfonylurea initiation in this observational comparison. The primary kidney endpoint combined at least 40% eGFR decline, end
- RSV and COVID-19 Vaccine Coadministration in Adults 50 Years and Olderhttps://reachmd.com/news/rsv-covid-19-vaccine-coadministration/2487387/Key Takeaways Noninferiority was achieved for RSV-A and RSV-B, while the upper bound of the 95% confidence interval for the Omicron XBB.1.5 SARS-CoV-2 comparison was just above the predefined cutoff. Same-visit vaccination was compared with sequential